SM
Sergio Martínez‐Hervás

Highly Cited


201
Works
2,509
Citations
28
H-Index
Search Authors
Author Statistics

Sergio Martínez‐Hervás

Also known as: Martinez Hervas, Sergio, Martínez-Hervás, Sergio, S Martinez-Hervas, S. Martinez Hervas, S. Martinez-Hervas

201

Total Works

2,509

Citations

28

H-Index

67

i10-Index

Citation & Works Trend by Year
22 years active
Top Research Topics
Lipoproteins and Cardiovascular Health (71) Cholesterol and Lipid Metabolism (47) Lipid metabolism and disorders (42) Diabetes, Cardiovascular Risks, and Lipoproteins (37) Atherosclerosis and Cardiovascular Diseases (36)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Silencing of RAB3A Reshapes the Extracellular Vesicle ncRNA Landscape in Diabetic Podocytes and Uncovers miR-126-3p as a Candidate Mediator of Podocyte Injury Biomolecules 0
2026 Efficacy, safety and predictors of response to minimally invasive treatments of the thyroid: a prospective study Endocrine 0
2026 Eficacia, seguridad y curva de aprendizaje de la ablación térmica con radiofrecuencia Endocrinología Diabetes y Nutrición 0
2026 LONG-TERM EFFICACY, TOLERABILITY, AND SAFETY OF LOMITAPIDE IN PAEDIATRIC PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLAEMIA (HOFH): POST-HOC ANALYSES OF THE APH-19 PHASE 3 CLINICAL TRIAL Atherosclerosis 0
2026 Effectiveness, safety, and treatment persistence of bempedoic acid in a Spanish real-world cohort Journal of clinical lipidology 0
2026 #Long-term efficacy, tolerability, and safety of lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH): post-hoc analyses of the APH-19 phase 3 clinical trial Journal of clinical lipidology 0
2026 RAB27A silencing modulates miR-30d-5p expression and extracellular vesicle non-coding RNA cargo in diabetic podocytes Scientific Reports 1
2026 Estándares SEA 2026 para el control global del riesgo vascular Clínica e Investigación en Arteriosclerosis 1
2026 Hypercholesterolemia Elsevier eBooks 0
2025 Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HoFH) – Analysis of long-term (104-week) safety and efficacy from the APH-19 study Atherosclerosis Plus 0
2025 Increased CX3CL1/CX3CR1 Axis Is Related to Atherosclerosis in Subjects with Familial Combined Hyperlipidaemia, Which Is Modulated by Insulin Resistance but Not by Sex Biomedicines 2
2025 Assessment of Muscle-Specific Strength in Oncology Patients: Anthropometry as a Reliable Alternative to DXA Life 1
2025 Lomitapide in paediatric patients with homozygous familial hypercholesterolaemia (HOFH) – Analysis of long-term (104-week) safety and efficacy from the APH-19 study Atherosclerosis 0
2025 The aggravation of atherosclerosis induced by inactivation of light (TNFSF14) is accompanied by a phenotypic change of vascular smooth muscle cells Atherosclerosis 0
2025 Integrating Artificial Intelligence in Thyroid Nodule Management: Clinical Outcomes and Cost-effectiveness Analysis The Journal of Clinical Endocrinology & Metabolism 8

Data source: OpenAlex API